Australian Prescriber

Australian Prescriber is an independent peer-reviewed journal providing critical commentary on drugs and therapeutics for health professionals.

SUBSCRIBE TO AUSTRALIAN PRESCRIBER

Subscribe to receive email updates when new Australian Prescriber articles are published

Subscribe now

  • Volume 45 Issue 2

  • April 2022

Oral antivirals for mild–moderate COVID‑19: a panacea or a logistical and clinical conundrum?

Oral antivirals for mild–moderate COVID‑19: a panacea or a logistical and clinical conundrum?
Editorial
Ian D Coombes, Amy Legg, Tina Patterson, Tanya Kelly, Andrew Henderson, Jason A Roberts
  • 1 April 2022
  • Podcast - Oral antivirals for mild–moderate COVID‑19: a panacea or a logistical and clinical conundrum?

The new oral antiviral drugs for COVID-19 were mainly studied in unvaccinated patients, before the emergence of the Omicron variant. Will they still be of benefit in 2022?
Article

Medicines for long-term obesity management

Medicines for long-term obesity management
Article

Medicines for long-term obesity management

Joseph Proietto AM
  • 1 April 2022
  • Podcast - Medicines for long-term obesity management

Patients with obesity often require drug therapy to maintain the weight loss achieved by diet.
Article

The assessment of severe cutaneous adverse drug reactions

The assessment of severe cutaneous adverse drug reactions
Article

The assessment of severe cutaneous adverse drug reactions

Ana M Copaescu, Jason A Trubiano
  • 1 April 2022
  • Podcast - The assessment of severe cutaneous adverse drug reactions

Severe cutaneous adverse drug reactions can be life-threatening. Patients who survive need to be investigated to determine the drug responsible and to assess the allergy.
Article

Antidepressants in adolescence

Antidepressants in adolescence
Article

Antidepressants in adolescence

Philip Hazell
  • 1 April 2022

Antidepressant drugs are not the first-line treatment for adolescents with mild symptoms of depression.
Abnormal laboratory results

Troponins in myocardial infarction and injury

Troponin-tests-Getty Images-1359869874
Abnormal laboratory results

Troponins in myocardial infarction and injury

Julia M Potter, Peter E Hickman, Louise Cullen
  • 1 April 2022
Letters to the Editor

Drugs for pain management in frail older people

Chronic-non-cancer-pain-elderly-Getty Images-508039694
Letters to the Editor

Drugs for pain management in frail older people

Peter Maguire
  • 1 April 2022
Letters to the Editor

Statin doses after acute coronary syndrome

Acute-coronary-syndromes-Getty Images-1270275522
Letters to the Editor

Statin doses after acute coronary syndrome

Simon B Dimmitt, Jennifer H Martin, Joanne Eng-Frost, Derek Chew
  • 1 April 2022

New drugs

Casirivimab and imdevimab for COVID-19

  • 1 April 2022

Molnupiravir for COVID-19

  • 1 April 2022

Nirmatrelvir and ritonavir for COVID-19

  • 1 April 2022

SARS-CoV-2 rS (NVX-CoV-2373) vaccine for prevention of COVID-19

  • 1 April 2022

Fostemsavir for HIV-1 infection

  • 1 April 2022

Lanadelumab for hereditary angioedema

  • 1 April 2022

Ravulizumab for paroxysmal nocturnal haemoglobinuria

  • 1 April 2022

Early release

Article

Anaphylaxis: emergency management for health professionals [Update 1]

  • 5 May 2022
New drug

Alpelisib for breast cancer

  • 29 April 2022
New drug

Eptinezumab for migraine

  • 29 April 2022

SUBSCRIBE TO AUSTRALIAN PRESCRIBER

Subscribe to receive email updates when new Australian Prescriber articles are published

Subscribe now
Online tool
Doctors Bag Hero